Pensionfund Sabic Purchases 6,000 Shares of Colgate-Palmolive (NYSE:CL)

Pensionfund Sabic boosted its position in Colgate-Palmolive (NYSE:CL - Free Report) by 43.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,700 shares of the company's stock after buying an additional 6,000 shares during the quarter. Pensionfund Sabic's holdings in Colgate-Palmolive were worth $1,791,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also bought and sold shares of the business. State Street Corp boosted its holdings in Colgate-Palmolive by 3.8% during the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company's stock valued at $5,028,170,000 after acquiring an additional 1,784,411 shares during the period. Geode Capital Management LLC boosted its stake in shares of Colgate-Palmolive by 2.8% during the third quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company's stock valued at $2,095,325,000 after purchasing an additional 552,949 shares during the period. Massachusetts Financial Services Co. MA boosted its stake in shares of Colgate-Palmolive by 6.2% during the third quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company's stock valued at $988,997,000 after purchasing an additional 557,492 shares during the period. Legal & General Group Plc grew its holdings in shares of Colgate-Palmolive by 0.8% in the second quarter. Legal & General Group Plc now owns 7,785,101 shares of the company's stock worth $755,465,000 after purchasing an additional 61,413 shares during the last quarter. Finally, Barclays PLC increased its stake in shares of Colgate-Palmolive by 38.7% in the third quarter. Barclays PLC now owns 7,644,189 shares of the company's stock worth $793,542,000 after buying an additional 2,132,747 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have issued reports on CL. Stifel Nicolaus lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and cut their price target for the stock from $105.00 to $101.00 in a report on Monday, October 28th. Wells Fargo & Company reduced their price target on Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating on the stock in a report on Monday, October 28th. StockNews.com upgraded Colgate-Palmolive from a "hold" rating to a "buy" rating in a report on Wednesday, January 1st. Deutsche Bank Aktiengesellschaft cut Colgate-Palmolive from a "buy" rating to a "hold" rating and boosted their target price for the company from $107.00 to $109.00 in a research note on Monday, September 9th. Finally, TD Cowen dropped their price target on Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company's stock. According to MarketBeat, Colgate-Palmolive presently has an average rating of "Moderate Buy" and an average target price of $104.63.

Insider Activity at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.34% of the stock is currently owned by insiders.

Colgate-Palmolive Stock Down 3.0 %

Shares of CL traded down $2.73 on Monday, hitting $87.42. 6,076,701 shares of the stock traded hands, compared to its average volume of 4,128,070. Colgate-Palmolive has a one year low of $79.69 and a one year high of $109.30. The company has a market capitalization of $71.42 billion, a PE ratio of 25.05, a P/E/G ratio of 3.31 and a beta of 0.44. The business has a 50 day simple moving average of $93.35 and a 200 day simple moving average of $98.44. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.29%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive's payout ratio is currently 57.31%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.